Abbas Agaimy is an expert in Surgery at Universitätsklinikum Erlangen (Germany). As of October 2026, ScienceLeadR ranks Abbas Agaimy in the top 1% of experts worldwide for Sarcoma, Adenoma and Carcinoma. Abbas Agaimy has authored 861 publications, the most recent in 2026, and is an investigator in 3 clinical trials, 1 of them ongoing. SLR score: 2,583 (community average: 125). How the SLR is computed.

LeadR Profile

2 583 ScienceLeadR Reputation 2583
Network Map

Surgery

Subspecialties: Oncology - Genetics - Endocrinology

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Organizations

Career arc: 2005 - 2026

Source: PubMed

Universitätsklinikum Erlangen

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 861

Citations

Citations: 20 659 1st author: 163 Last author: 115 Unique author: 37


Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Yersinia Enterocolitica Infection Mimicking Colon Carcinoma With Hepatic Metastases.
PMID 42929000 — yersinia, yersinia infections, colon, yersinia enterocolitica, neoplasm metastasis, gastrointestinal diseases, infections
United European Gastroenterol J20260
Neuroendocrine Tumors (NETs) of the Larynx.
PMID 42882251 — genes, larynx, neoplasms, classification, neuroendocrine tumors, diagnosis, prognosis
Diagnostics (Basel)20260
Vulvovaginal Epithelioid Mesenchymal Neoplasm With "Deciduoid" Morphology: Report of a Novel Entity Frequently Associated With Inactivating Germline BAP1 Variants.
PMID 42860666 — cells, genes, immunohistochemistry, neoplasms, vulva, receptors, progesterone, vagina
Am J Surg Pathol20260
Pilomatrix-like high grade carcinomas involving urinary bladder: a novel divergent differentiation in urothelial carcinoma.
PMID 42828537 — urinary bladder, cells, catenins, neoplasms, pathology, mutation
Virchows Arch20260
The indolent nature of gastroblastoma. Report of an illustrative case with 28 years of follow-up showing previously unreported immunohistochemical and molecular features.
PMID 42778800 — cells, somatostatin, neoplasms, pathology
Virchows Arch20260

Clinical Studies 3

Sources: ClinicalTrials, EU CTIS

Synthesis

By phase:

N/A 3

By status:

Completed 2
Recruiting 1

By type:

Interventional 2
Observational 1

By Monocentric/Multicentric:

monocentric 1
multicentric2to4 1
multicentric5to9 1
multicentricup10 0

Main Topics

Ongoing Clinical Trials

Ongoing trial started since 2021, where this expert is an investigator

Source: ClinicalTrials

Study Phase Status Start
Immune Biomarker Study for Salivary Gland Carcinoma
NCT06047236 — blood, salivary glands, neoplasms, salivary gland neoplasms, biomarkers, therapeutics, carcinoma
N/ARecruiting2024

LeadR Networks

Main global connection map